RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCI SCIE SCOPUS

      New Scoring System for Predicting Mortality in Patients with COVID-19

      한글로보기

      https://www.riss.kr/link?id=A107820805

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: We aimed to develop a novel mortality scoring system for inpatients with COVID-19 based on simple demographic factorsand laboratory findings. Materials and Methods: We reviewed and analyzed data from patients who were admitted and diagnosed w...

      Purpose: We aimed to develop a novel mortality scoring system for inpatients with COVID-19 based on simple demographic factorsand laboratory findings.
      Materials and Methods: We reviewed and analyzed data from patients who were admitted and diagnosed with COVID-19 at 10hospitals in Daegu, South Korea, between January and July 2020. We randomized and assigned patients to the development andvalidation groups at a 70% to 30% ratio. Each point scored for selected risk factors helped build a new mortality scoring system usingCox regression analysis. We evaluated the accuracy of the new scoring system in the development and validation groups usingthe area under the curve.
      Results: The development group included 1232 patients, whereas the validation group included 528 patients. In the developmentgroup, predictors for the new scoring system as selected by Cox proportional hazards model were age ≥70 years, diabetes, chronickidney disease, dementia, C-reactive protein levels >4 mg/dL, infiltration on chest X-rays at the initial diagnosis, and the need foroxygen support on admission. The areas under the curve for the development and validation groups were 0.914 [95% confidenceinterval (CI) 0.891–0.937] and 0.898 (95% CI 0.854–0.941), respectively. According to our scoring system, COVID-19 mortality was0.4% for the low-risk group (score 0–3) and 53.7% for the very high-risk group (score ≥11).
      Conclusion: We developed a new scoring system for quickly and easily predicting COVID-19 mortality using simple predictors.
      This scoring system can help physicians provide the proper therapy and strategy for each patient.

      더보기

      참고문헌 (Reference)

      1 Maroldi R, "Which role for chest x-ray score in predicting the outcome in COVID-19 pneumonia?" 31 : 4016-4022, 2021

      2 Kermali M, "The role of biomarkers in diagnosis of COVID-19 : a systematic review" 254 : 117788-, 2020

      3 Guo S, "The moderate predictive value of serial serum CRP and PCT levels for the prognosis of hospitalized community-acquired pneumonia" 19 : 193-, 2018

      4 Grifoni E, "The CALL score for predicting outcomes in patients with COVID-19" 72 : 182-183, 2021

      5 Shang Y, "Scoring systems for predicting mortality for severe patients with COVID-19" 24 : 100426-, 2020

      6 Li X, "Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan" 146 : 110-118, 2020

      7 Lee Ji Yeon, "Risk Factors for Mortality and Respiratory Support in Elderly Patients Hospitalized with COVID-19 in Korea" 대한의학회 35 (35): 1-12, 2020

      8 Beigel JH, "Remdesivir for the treatment of COVID-19-final report" 383 : 1813-1826, 2020

      9 Luo X, "Prognostic value of c-reactive protein in patients with coronavirus 2019" 71 : 2174-2179, 2020

      10 Jang Jong Geol, "Prognostic Accuracy of the SIRS, qSOFA, and NEWS for Early Detection of Clinical Deterioration in SARS-CoV-2 Infected Patients" 대한의학회 35 (35): 1-10, 2020

      1 Maroldi R, "Which role for chest x-ray score in predicting the outcome in COVID-19 pneumonia?" 31 : 4016-4022, 2021

      2 Kermali M, "The role of biomarkers in diagnosis of COVID-19 : a systematic review" 254 : 117788-, 2020

      3 Guo S, "The moderate predictive value of serial serum CRP and PCT levels for the prognosis of hospitalized community-acquired pneumonia" 19 : 193-, 2018

      4 Grifoni E, "The CALL score for predicting outcomes in patients with COVID-19" 72 : 182-183, 2021

      5 Shang Y, "Scoring systems for predicting mortality for severe patients with COVID-19" 24 : 100426-, 2020

      6 Li X, "Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan" 146 : 110-118, 2020

      7 Lee Ji Yeon, "Risk Factors for Mortality and Respiratory Support in Elderly Patients Hospitalized with COVID-19 in Korea" 대한의학회 35 (35): 1-12, 2020

      8 Beigel JH, "Remdesivir for the treatment of COVID-19-final report" 383 : 1813-1826, 2020

      9 Luo X, "Prognostic value of c-reactive protein in patients with coronavirus 2019" 71 : 2174-2179, 2020

      10 Jang Jong Geol, "Prognostic Accuracy of the SIRS, qSOFA, and NEWS for Early Detection of Clinical Deterioration in SARS-CoV-2 Infected Patients" 대한의학회 35 (35): 1-10, 2020

      11 Kodama T, "Prediction of an increase in oxygen requirement of SARSCoV-2 pneumonia using three different scoring systems" 27 : 336-341, 2021

      12 Ji D, "Prediction for progression risk in patients with COVID-19 pneumonia : the CALL score" 71 : 1393-1399, 2020

      13 Chen W, "Plasma CRP level is positively associated with the severity of COVID-19" 19 : 18-, 2020

      14 Satici C, "Performance of pneumonia severity index and CURB65 in predicting 30-day mortality in patients with COVID-19" 98 : 84-89, 2020

      15 Cohen MS, "Monoclonal antibodies to disrupt progression of early COVID-19 infection" 384 : 289-291, 2021

      16 Cheng Y, "Kidney disease is associated with in-hospital death of patients with COVID-19" 97 : 829-838, 2020

      17 Wang Z, "Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients" 164 : 108214-, 2020

      18 Chen D, "Exposure to SARS-CoV-2 in a high transmission setting increases the risk of severe COVID-19 compared with exposure to a low transmission setting?" 27 : taaa094-, 2020

      19 Feng Z, "Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics" 11 : 4968-, 2020

      20 RECOVERY Collaborative Group, "Dexamethasone in hospitalized patients with COVID-19" 384 : 693-704, 2021

      21 Gue YX, "Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19" 10 : 21379-, 2020

      22 Mancilla-Galindo J, "Development and validation of the patient history COVID-19(PH-Covid19)scoring system : a multivariable prediction model of death in Mexican patients with COVID-19" 148 : e286-, 2020

      23 Liang W, "Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19" 180 : 1081-1089, 2020

      24 King JT Jr, "Development and validation of a 30-day mortality index based on pre-existing medical administrative data from 13, 323 COVID-19 patients : the Veterans Health Administration COVID-19(VACO)index" 15 : e0241825-, 2020

      25 Guan WJ, "Comorbidity and its impact on 1590 patients with COVID-19 in China : a nationwide analysis" 55 : 2000547-, 2020

      26 Harrison SL, "Comorbidities associated with mortality in 31, 461 adults with COVID-19 in the United States : a federated electronic medical record analysis" 17 : e1003321-, 2020

      27 Huang C, "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China" 395 : 497-506, 2020

      28 Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study" 395 : 1054-1062, 2020

      29 Kim Shin-Woo, "Clinical Characteristics and Outcomes of COVID-19 Cohort Patients in Daegu Metropolitan City Outbreak in 2020" 대한의학회 36 (36): 1-15, 2021

      30 Borghesi A, "Chest X-ray severity index as a predictor of in-hospital mortality in coronavirus disease 2019 : a study of 302 patients from Italy" 96 : 291-293, 2020

      31 Borghesi A, "COVID-19 outbreak in Italy : experimental chest X-ray scoring system for quantifying and monitoring disease progression" 125 : 509-513, 2020

      32 Kalil AC, "Baricitinib plus remdesivir for hospitalized adults with COVID-19" 384 : 795-807, 2021

      33 Fang L, "Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?" 8 : e21-, 2020

      34 Altschul DJ, "A novel severity score to predict inpatient mortality in COVID-19 patients" 10 : 16726-, 2020

      35 Zhang C, "A novel scoring system for prediction of disease severity in COVID-19" 10 : 318-, 2020

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-05-31 학술지등록 한글명 : Yonsei Medical Journal
      외국어명 : Yonsei Medical Journal
      KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2000-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.42 0.3 0.99
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.83 0.72 0.546 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼